Pharma International Pty Ltd Mayne serves as Executive at HedgePath Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Pharma International Pty Ltd Mayne has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 15, 2021 involved transacting 2,240,488 shares valued at $0.
Pharma International Pty Ltd Mayne currently holds 0 shares of HedgePath Pharmaceuticals, Inc. (HPPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharma International Pty Ltd Mayne has been a net neutral trader of HPPI stock. They have purchased $0 and sold $0 worth of shares.
Pharma International Pty Ltd Mayne's most recent insider trade was on Jan 15, 2021, when they sold 2,240,488 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 15, 2019 | HPPI | $0 | Other | 362,121 | $N/A | Discretionary |
| Dec 19, 2017 | HPPI | $0 | Purchase | 600,000 | $N/A | Discretionary |
| Nov 15, 2016 | HPPI | $0 | Exercise | 4,750,569 | $N/A | Discretionary |
| Nov 15, 2016 | HPPI | $0 | Exercise | 4,860,000 | $N/A | Discretionary |
| Nov 15, 2016 | HPPI | $0 | Exercise | 333 | $N/A | Discretionary |
| Nov 4, 2016 | HPPI | $0 | Exercise | 33,333,000 | $N/A | Discretionary |
| Nov 4, 2016 | HPPI | $0 | Exercise | 5,500,000 | $N/A | Discretionary |
| May 15, 2015 | HPPI | $0 | Award | 33,333,333 | $N/A | Discretionary |